NAYA NAYA Bio: יחס שווי שוק לערך בספרים

The current market capitalization to book value assessment on GURU.Markets includes the -0.11 indicator, which determines the metric's magnitude. NAYA Biosciences (NAYA) growth is based on integration with INVO, successes in antibody therapy, and IVF services. Patents for the FLEX-NK platform serve as a defense against acquisition, while the efficiency of R&D laboratories is ensured by strict control over the depreciation of high-tech equipment.

This ratio compares the market value of the business to its net assets, measuring the premium over capital. Investors use this metric to assess asset overvaluation relative to their liquidation value. By analyzing the dynamics of the market-to-book ratio, one can identify the sensitivity of quotes to the cost of borrowed capital. For NAYA Biosciences (NAYA), this is critical due to the lack of revenue and the early stages of drug development. The risk of a cash crunch makes the dependence on speculative capital the determining factor.